Guillaume Blivet, MPH
Primary tabs
JAD profile
Affiliation(s):
REGENLIFE
Lab URL:
ORCID URL:
Areas of Interest:
dementia, multiple sclerosis, depression, Alzheimer's disease, AD: Alzheimer Disease, TBI, mTBI, Alzheimers clinical trials, Brain Photobiomodulation, photobiomodulation, Neurostimulation, Healthy ageing, geroscience
Biography & Research:
Guillaume Blivet is an entrepreneur and an innovator with 15+ years of global experience in multiple areas of healthcare, medical technologies, and disease management. Guillaume specializes in public health (MPH) and is also graduated with an Executive MBA. He is Chief Innovation Officer of REGEnLIFE, a NeuroTech he has founded in 2016. This company develops a novel medical device dedicated to people living with neurodegenerative diseases, specifically Alzheimer’s disease. This patented therapeutic solution is a non-invasive and painless application which takes the form of a helmet and an abdominal belt which together target both the brain and the gut. A first pilot clinical trial has been completed and other preclinical and clinical developments are underway.
